Qibin Leng

78 Heng Zhi Gang, Lu Hu Road
Guangzhou, 510095, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Site-specific neoepitope induction by RNA editing reprograms tumor immunogenicity.

Site-specific neoepitope induction by RNA editing reprograms tumor immunogenicity.

Journal: Frontiers in immunology

Published: March 26, 2026

In situ DC-primed vaccine combined with CD137 agonist elicits long-lasting antitumor immunity through cDC1-mediated tumor antigen-specific CD8+ T cell responses.

In situ DC-primed vaccine combined with CD137 agonist elicits long-lasting antitumor immunity through cDC1-mediated tumor antigen-specific CD8+ T cell responses.

Journal: Journal for immunotherapy of cancer

Published: November 15, 2025

LTO1 and YAE1 regulate MHC-I expression via nonsense-mediated RNA decay in tumor cells.

LTO1 and YAE1 regulate MHC-I expression via nonsense-mediated RNA decay in tumor cells.

Journal: Journal for immunotherapy of cancer

Published: August 27, 2025

Prognostic value of diffusion-weighted imaging to cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for patients with gastric cancer and peritoneal metastases.

Prognostic value of diffusion-weighted imaging to cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for patients with gastric cancer and peritoneal metastases.

Journal: BMC cancer

Published: January 14, 2025

Dietary nucleic acids promote oral tolerance through innate sensing pathways in mice.

Dietary nucleic acids promote oral tolerance through innate sensing pathways in mice.

Journal: Nature communications

Published: February 26, 2024

Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response.

Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response.

Journal: Nature cancer

Published: March 25, 2023

Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunity.

Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunity.

Journal: The Journal of clinical investigation

Published: June 22, 2022

GPI-anchored ligand-BioID2-tagging system identifies Galectin-1 mediating Zika virus entry.

GPI-anchored ligand-BioID2-tagging system identifies Galectin-1 mediating Zika virus entry.

Journal: iScience

Published: April 05, 2022

Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.

Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.

Journal: Cell reports

Published: March 08, 2022

Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo.

Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo.

Journal: Emerging microbes & infections

Published: March 07, 2022

Precise tumor immune rewiring via synthetic CRISPRa circuits gated by concurrent gain/loss of transcription factors.

Precise tumor immune rewiring via synthetic CRISPRa circuits gated by concurrent gain/loss of transcription factors.

Journal: Nature communications

Published: July 29, 2021

Single-cell analyses reveal suppressive tumor microenvironment of human colorectal cancer.

Single-cell analyses reveal suppressive tumor microenvironment of human colorectal cancer.

Journal: Clinical and translational medicine

Published: December 11, 2020

Showing 1-12 of 60

Last Updated: 09/26/2026